U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06976489) titled 'The Food Effect on PK Characteristics and Safety Profiles of PA-111' on May 09.
Brief Summary: Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of PA-111 in healthy subjects.
Study Start Date: May, 2025
Study Type: INTERVENTIONAL
Condition:
Mixed Dyslipidemia
Intervention:
DRUG: PA-111
PA-111 1Tab., Per Oral
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Addpharma Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....